News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Microbiome-focused company, Kaleido Biosciences, in a filing with the US Securities and Exchange Commission (SEC) on Friday, announced its intention to cease all company operations, lay off its remaining staff and delist from the Nasdaq Exchange.
BioNTech is teaming up with Matinas BioPharma in a research collaboration to explore novel formulations for mRNA vaccines, including oral vaccines.
The US Centers for Medicare & Medicaid Services (CMS) has confirmed it will limit coverage of Alzheimer’s drug Aduhelm coverage to clinical trials.
Lonza has added new integrated capabilities in cell binding, cell separation, and bead removal to its closed, automated, and scalable platform for personalized therapy manufacturing.